Answers are grounded in this paper and cite their sources.
Pheochromocytoma is a rare malignancy. The opportunity to gain experience with persistent and recurrent pheochromocytoma is extremely limited. We have, therefore, reviewed our experience with 8 patients with persistent and recurrent pheochromocytoma treated during the last 6 years. In patients with multiple endocrine neoplasia, the recurrent or persistent adrenal tumor is usually situated in the contralateral adrenal, whereas in other patients the tumor is usually situated in an ectopic position or is due to recognized or unrecognized malignant disease. Survival from diagnosis ranged from 1.5 to 23 years in these patients. Because long‐term survival may occur following removal of both benign and malignant pheochromocytomas, an aggressive surgical approach is recommended.
No takes yet. Share an insight, caveat, or question.
Brennan et al. (1982) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: